Rui Avelar
Direttore Tecnico/Scientifico/R&S presso EVOLUS, INC.
Patrimonio netto: 5 M $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Moatazedi | M | 46 | 6 anni | |
| Robert Hayman | M | 65 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 10 anni |
| Karah Parschauer | F | 46 | 5 anni | |
| Brady Stewart | M | 48 | 2 anni | |
| Kurt Knab | M | - | 6 anni | |
| David Gill | M | 69 | 6 anni | |
| Vikram Malik | M | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 6 anni |
| Simone Blank | F | 61 | 6 anni | |
| Nareg Sagherian | M | - | - | |
| Christopher Paige | M | 71 |
University of Toronto
| 37 anni |
| Jeffrey J. Plumer | M | - | 10 anni | |
| Jost Fischer | M | 69 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 7 anni |
| Harry Ruda | M | 65 |
University of Toronto
| 35 anni |
| Dan Stewart | M | - | 3 anni | |
| Jessica Novak | F | - | 3 anni | |
| Christos Monovoukas | M | - | 2 anni | |
| Sandra Beaver | F | 46 | 2 anni | |
| Tomoko Yamagishi-Dressler | F | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Murthy Simhambhatla | M | 58 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 anni |
| J. Marmo | M | 55 | - | |
| Stuart R. Nayman | M | - |
University of Toronto
| 7 anni |
| Ashwin K. Agarwal | M | - | 3 anni | |
| Kristine Romine | M | 59 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 anni |
| Valdis Martinsons | M | - |
University of Toronto
| 7 anni |
| Bosun Hau | M | 45 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 anni |
| Joseph Cargnelli | M | 54 |
University of Toronto
| 6 anni |
| John Docherty | M | 53 |
University of Toronto
| 6 anni |
| Chris Ouslis | M | - |
University of Toronto
| 6 anni |
| Davin Andrew Gibbins | M | - |
University of Toronto
| 5 anni |
| Andrew Pyle | M | - |
University of Toronto
| 5 anni |
| Mazen Hassounah | M | - |
University of Toronto
| 5 anni |
| Brian Miron | M | - |
University of Toronto
| 5 anni |
| Andrew Woo | M | - |
University of Toronto
| 6 anni |
| Wai Cheong Ng | M | 55 |
University of Toronto
| 7 anni |
| Crystal Muilenburg | F | 45 | 4 anni | |
| Fiona J. Kelly | F | - |
University of Toronto
| 3 anni |
| Ira Kagan | M | 61 |
University of Toronto
| 7 anni |
| Hamid Mumin | M | - |
University of Toronto
| 4 anni |
| Bob Rhatigan | M | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | - |
| Jonathan Anschell | M | 56 |
University of Toronto
| 6 anni |
| Cheong Szeto | M | 54 |
University of Toronto
| 6 anni |
| Kris Garcia | M | - | - | |
| Michael Mazen Jafar | M | 42 | 3 anni | |
| Anna Marie Tham | F | 60 |
University of Toronto
| 6 anni |
| Flora Wood | F | - |
University of Toronto
| 5 anni |
| Kwok Cheung Chan | M | 62 |
University of Toronto
| 6 anni |
| Richard Romano | M | - |
University of Toronto
| 6 anni |
| Jon A. Douglas | M | 61 |
University of Toronto
| 4 anni |
| Bill Maslechko | M | 63 |
University of Toronto
| 4 anni |
| Peter Farrell | M | 81 | - | |
| Gerald D. Mintz | M | 71 |
University of Toronto
| 3 anni |
| Alicia Damley | F | - |
University of Toronto
| 7 anni |
| Lauren Silvernail | F | 65 | 4 anni | |
| Domenic A. Rinaldi | M | - |
University of Toronto
| 4 anni |
| Gregory P. Downey | M | - |
University of Toronto
| 4 anni |
| Tom Meyer | M | 56 |
University of Toronto
| 4 anni |
| Brian Ostroff | M | - |
University of Toronto
| 4 anni |
| Suneet Singh Tuli | M | 54 |
University of Toronto
| 4 anni |
| Colin White | M | - |
University of Toronto
| 4 anni |
| Chi Yu Yu | M | 63 |
University of Toronto
| 4 anni |
| Hugues Simard | M | 56 |
University of Toronto
| 4 anni |
| Warren John Stoddart | M | - |
University of Toronto
| 4 anni |
| David William Briggs | M | - |
University of Toronto
| 4 anni |
| Jim Athanasopoulos | M | 54 |
University of Toronto
| 4 anni |
| C. Barry McLean | M | - |
University of Toronto
| 2 anni |
| Jill A. MacRae | F | - |
University of Toronto
| 4 anni |
| Raja Arian Abbasi | M | 58 |
University of Toronto
| 4 anni |
| Monique Rabideau | F | - |
University of Toronto
| 3 anni |
| Shuk Kwan Lui | F | 58 |
University of Toronto
| 4 anni |
| Caroline Gillespie | F | - |
University of Toronto
| 5 anni |
| Dennis Wolf | M | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 anni |
| Alison Wright | F | - |
University of Toronto
| 4 anni |
| Mark Kociancic | M | 54 |
University of Toronto
| 4 anni |
| Kelly Battle | F | - |
University of Toronto
| 4 anni |
| Heather Takahashi | F | - |
University of Toronto
| 3 anni |
| Robert Almeida | M | 61 |
University of Toronto
| 4 anni |
| Colin Foster | M | 61 |
University of Toronto
| 4 anni |
| Elmer Kim | M | - |
University of Toronto
| 4 anni |
| Ene Liis Palmer | F | - |
University of Toronto
| 3 anni |
| Anna Marks | F | - |
University of Toronto
| 4 anni |
| Victor Alksnis | M | - |
University of Toronto
| 4 anni |
| Michael Vinke | M | - |
University of Toronto
| 3 anni |
| Howard Verrico | M | - |
University of Toronto
| 3 anni |
| Jason Lester | M | 62 |
University of Toronto
| 4 anni |
| Brian T. McGee | M | 63 |
University of Toronto
| 4 anni |
| Philip Evershed | M | 63 |
University of Toronto
| 1 anni |
| Kresimir Begic | M | - |
University of Toronto
| 4 anni |
| Trevor Haynes | M | 57 |
University of Toronto
| 4 anni |
| Wendy Ford | F | - |
University of Toronto
| 4 anni |
| MacMurray D. Whale | M | - |
University of Toronto
| 4 anni |
| Paul Mancuso | M | 59 |
University of Toronto
| 4 anni |
| Jim McGovern | M | 61 |
University of Toronto
| 4 anni |
| Christopher Wei | M | 55 |
University of Toronto
| 4 anni |
| Ara P. Arzumanian | M | 55 |
University of Toronto
| 4 anni |
| Clifford Hale-Sanders | M | - |
University of Toronto
| 4 anni |
| Wai Yee Yiu | F | 56 |
University of Toronto
| 4 anni |
| James Ngai | M | 61 |
University of Toronto
| 4 anni |
| Catherine Elizabeth Payne | F | - |
University of Toronto
| 4 anni |
| Rudy Gobin | M | 62 |
University of Toronto
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 71 | 71.72% |
| Stati Uniti | 28 | 28.28% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Rui Avelar
- Contatti personali
